Why is Medpace Holdings, Inc. ?
1
Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 48.42%
- Healthy long term growth as Net Sales has grown by an annual rate of 22.27% and Operating profit at 26.21%
- Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.05 times
2
The company has declared Positive results for the last 7 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 713.23 MM
- NET SALES(Q) Highest at USD 708.45 MM
- DEBT-EQUITY RATIO (HY) Lowest at -78.46 %
3
High Institutional Holdings at 97.28%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Market Beating Performance
- The stock has generated a return of 42.51% in the last 1 year, much higher than market (S&P 500) returns of 11.87%
How much should you buy?
- Overall Portfolio exposure to Medpace Holdings, Inc. should be less than 10%
- Overall Portfolio exposure to Miscellaneous should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Medpace Holdings, Inc. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Medpace Holdings, Inc.
35.41%
0.17
67.80%
S&P 500
32.23%
0.62
19.30%
Quality key factors
Factor
Value
Sales Growth (5y)
22.27%
EBIT Growth (5y)
26.21%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.70
Sales to Capital Employed (avg)
4.45
Tax Ratio
13.49%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
97.28%
ROCE (avg)
105.06%
ROE (avg)
48.42%
Valuation Key Factors 
Factor
Value
P/E Ratio
29
Industry P/E
Price to Book Value
28.11
EV to EBIT
23.24
EV to EBITDA
22.08
EV to Capital Employed
-841.82
EV to Sales
4.91
PEG Ratio
1.24
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
98.27%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Bullish
Technical Movement
14What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 713.23 MM
NET SALES(Q)
Highest at USD 708.45 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -78.46 %
DEBTORS TURNOVER RATIO(HY)
Highest at 7.24 times
OPERATING PROFIT(Q)
Highest at USD 160.4 MM
PRE-TAX PROFIT(Q)
Highest at USD 156.83 MM
NET PROFIT(Q)
Highest at USD 135.13 MM
EPS(Q)
Highest at USD 4.67
-1What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 12.52% (YoY
Here's what is working for Medpace Holdings, Inc.
Operating Cash Flow
Highest at USD 713.23 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 708.45 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Net Sales
At USD 708.45 MM has Grown at 32.03%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD 160.4 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Pre-Tax Profit
Highest at USD 156.83 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 135.13 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 4.67
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Debt-Equity Ratio
Lowest at -78.46 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 7.24 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Medpace Holdings, Inc.
Raw Material Cost
Grown by 12.52% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






